Enlivex Therapeutics Ltd. (ENLV) Financials

$0.95

$0.01 (1.1%)
Last update: 04:00 PM EST
Day's range
$0.93
Day's range
$0.98
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning20182018201920192020202020212021202220222023202320242024-607%-607%-607.5%-607.5%-608%-608%-608.5%-608.5%-609%-609%-609.5%-609.5%-610%-610%Profit Margin
Profit Margin
Revenue
Earnings

ENLV Income statement / Annual

Last year (2024), Enlivex Therapeutics Ltd.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Enlivex Therapeutics Ltd.'s net income was -$15.01 M. See Enlivex Therapeutics Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $2.28 M $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $545,000.00 $835,000.00 $777,000.00 $546,000.00 $286,000.00 $297,000.00 $121,000.00 $12,000.00 $25,000.00 $17,000.00
Gross Profit -$545,000.00 -$835,000.00 -$777,000.00 -$546,000.00 $1.99 M -$297,000.00 -$121,000.00 -$12,000.00 -$25,000.00 -$17,000.00
Gross Profit Ratio 0 0 0 0 0.87 0 0 0 0 0
Research and Development Expenses $10.13 M $19.24 M $18.69 M $12.88 M $6.09 M $5.72 M $4.26 M $2.52 M $8.88 M $7.69 M
General & Administrative Expenses $0.00 $6.14 M $6.70 M $6.24 M $3.60 M $2.75 M $937,000.00 $2.96 M $6.99 M $6.95 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $479,000.00 $0.00 $829,000.00
Selling, General & Administrative Expenses $4.87 M $6.14 M $6.70 M $6.24 M $3.60 M $2.75 M $937,000.00 $3.44 M $6.99 M $7.78 M
Other Expenses $0.00 $4.02 M $402,000.00 $167,000.00 $97,000.00 $145,000.00 $0.00 $0.00 $0.00 -$829,000.00
Operating Expenses $14.99 M $29.40 M $25.80 M $19.29 M $9.79 M $8.62 M $5.30 M $5.96 M $15.87 M $15.48 M
Cost And Expenses -$15.54 M $29.40 M $25.80 M $19.29 M $9.79 M $8.62 M $5.30 M $5.96 M $15.87 M $15.48 M
Interest Income $1.07 M $1.57 M $835,000.00 $120,000.00 $225,000.00 $238,000.00 $138,000.00 $39,000.00 $90,000.00 $186,000.00
Interest Expense $0.00 $14,000.00 $5.26 M $328,000.00 $6,000.00 $7,000.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $545,000.00 $835,000.00 $777,000.00 $546,000.00 $286,000.00 $297,000.00 $121,000.00 $12,000.00 $25,000.00 $17,000.00
EBITDA -$14.47 M -$28.22 M -$25.02 M -$18.74 M -$9.50 M -$9.08 M -$5.18 M -$5.91 M -$15.78 M -$15.31 M
EBITDA Ratio 0 0 0 0 -4.17 0 0 0 0 0
Operating Income Ratio 0 0 0 0 -4.3 0 0 0 0 0
Total Other Income/Expenses Net $522,000.00 $327,000.00 -$5.26 M $4.82 M -$2.04 M -$765,000.00 $1.06 M -$67,000.00 -$1.86 M $135,000.00
Income Before Tax -$15.01 M -$29.07 M -$31.06 M -$14.47 M -$11.82 M -$9.38 M -$4.24 M -$5.92 M -$15.81 M -$15.34 M
Income Before Tax Ratio 0 0 0 0 -5.19 0 0 0 0 0
Income Tax Expense $0.00 $0.00 $11.35 M -$4.82 M $2.04 M $765,000.00 $1.06 M $28,000.00 $216,000.00 $24,000.00
Net Income -$15.01 M -$29.07 M -$42.41 M -$9.65 M -$13.86 M -$10.15 M -$4.24 M -$5.95 M -$16.02 M -$15.37 M
Net Income Ratio 0 0 0 0 -6.09 0 0 0 0 0
EPS -0.73 -1.56 -2.31 -0.54 -1.05 -1.17 -1.21 -14.35 -40.29 -43.19
EPS Diluted -0.73 -1.56 -2.31 -0.54 -1.05 -1.17 -1.21 -13.88 -40.29 -43.19
Weighted Average Shares Out $20.51 M $18.57 M $18.39 M $17.86 M $13.17 M $8.65 M $3.51 M $414,204.00 $397,655.00 $355,762.00
Weighted Average Shares Out Diluted $20.51 M $18.57 M $18.39 M $17.86 M $13.17 M $8.65 M $3.51 M $428,241.00 $397,655.00 $355,762.00
Link